Preventive screenings boost outcomes and lower costs by enabling early cancer detection and reducing treatment expenses for BCBS members.

A new study led by researchers at Moffitt Cancer Center found that blood-based DNA markers known as protein epiScores can help predict which colorectal cancer patients face a higher risk of cancer ...

The FDA has granted priority review to the supplemental biologics license application for datopotamab deruxtecan (Dato-DXd) ...

A new study in mice hints at the potential to use tiny particles made with RNA molecules to deliver chemotherapy drugs and other therapies directly to tumors, killing cancer cells without generating ...

"Sometimes, patients may not think they have cancer if they do not have a family history and may mistake a lump for an ...

Colorectal cancer has long baffled scientists because, unlike most tumors, patients often do better when their cancers are ...

At least eight babies have been born to patients who underwent the procedure. This week I want to tell you about an ...

A new study reveals that cancer patients diagnosed during the early COVID-19 pandemic had worse short-term survival rates ...

Zanzalintinib is an investigational oral agent that inhibits tyrosine kinase receptors associated with cancer growth, including TYRO3, VEGF, MET, AXL, and MER.

This could change how we think about treating cancer. Researchers at KAIST led by Kwang-Hyun Cho have developed a method that ...

In cellular and animal models of neuroblastoma, small cell lung cancer and colon cancer, this strategy reduces tumours, ...